ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRNIP1 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_35691017 | 8.02 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr1_-_20812690 | 7.49 |
ENST00000375078.3 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr14_-_105420241 | 6.81 |
ENST00000557457.1 |
AHNAK2 |
AHNAK nucleoprotein 2 |
chrX_-_38080077 | 6.02 |
ENST00000378533.3 ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX |
sushi-repeat containing protein, X-linked |
chr8_+_22437965 | 5.39 |
ENST00000409141.1 ENST00000265810.4 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr12_-_77272765 | 5.27 |
ENST00000547435.1 ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2 |
cysteine and glycine-rich protein 2 |
chr7_-_41740181 | 5.18 |
ENST00000442711.1 |
INHBA |
inhibin, beta A |
chr11_+_114128522 | 5.05 |
ENST00000535401.1 |
NNMT |
nicotinamide N-methyltransferase |
chr3_+_105085734 | 5.02 |
ENST00000306107.5 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr5_+_135385202 | 5.02 |
ENST00000514554.1 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr6_+_17393839 | 4.83 |
ENST00000489374.1 ENST00000378990.2 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr6_+_17393888 | 4.81 |
ENST00000493172.1 ENST00000465994.1 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr11_+_69455855 | 4.80 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr12_+_53491220 | 4.46 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr1_-_153518270 | 4.43 |
ENST00000354332.4 ENST00000368716.4 |
S100A4 |
S100 calcium binding protein A4 |
chr1_-_153538292 | 4.35 |
ENST00000497140.1 ENST00000368708.3 |
S100A2 |
S100 calcium binding protein A2 |
chr8_-_41166953 | 4.34 |
ENST00000220772.3 |
SFRP1 |
secreted frizzled-related protein 1 |
chr11_-_111784005 | 4.33 |
ENST00000527899.1 |
CRYAB |
crystallin, alpha B |
chr10_-_126849588 | 4.29 |
ENST00000411419.2 |
CTBP2 |
C-terminal binding protein 2 |
chr11_-_12030629 | 4.24 |
ENST00000396505.2 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr16_-_10674528 | 4.23 |
ENST00000359543.3 |
EMP2 |
epithelial membrane protein 2 |
chr8_+_97506033 | 4.20 |
ENST00000518385.1 |
SDC2 |
syndecan 2 |
chr2_-_106015527 | 4.06 |
ENST00000344213.4 ENST00000358129.4 |
FHL2 |
four and a half LIM domains 2 |
chr16_-_65155979 | 4.05 |
ENST00000562325.1 ENST00000268603.4 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr2_-_161350305 | 4.04 |
ENST00000348849.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr11_-_111783919 | 3.99 |
ENST00000531198.1 ENST00000533879.1 |
CRYAB |
crystallin, alpha B |
chr16_+_55512742 | 3.95 |
ENST00000568715.1 ENST00000219070.4 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr11_-_111783595 | 3.86 |
ENST00000528628.1 |
CRYAB |
crystallin, alpha B |
chr7_+_65670186 | 3.84 |
ENST00000304842.5 ENST00000442120.1 |
TPST1 |
tyrosylprotein sulfotransferase 1 |
chr14_-_75079026 | 3.77 |
ENST00000261978.4 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
chr10_+_75670862 | 3.74 |
ENST00000446342.1 ENST00000372764.3 ENST00000372762.4 |
PLAU |
plasminogen activator, urokinase |
chr1_-_153599426 | 3.73 |
ENST00000392622.1 |
S100A13 |
S100 calcium binding protein A13 |
chr2_-_161349909 | 3.70 |
ENST00000392753.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr1_-_153522562 | 3.70 |
ENST00000368714.1 |
S100A4 |
S100 calcium binding protein A4 |
chr2_+_241375069 | 3.66 |
ENST00000264039.2 |
GPC1 |
glypican 1 |
chr10_+_54074033 | 3.63 |
ENST00000373970.3 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
chr3_+_105086056 | 3.63 |
ENST00000472644.2 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr2_-_106015491 | 3.63 |
ENST00000408995.1 ENST00000393353.3 ENST00000322142.8 |
FHL2 |
four and a half LIM domains 2 |
chr7_-_93519471 | 3.62 |
ENST00000451238.1 |
TFPI2 |
tissue factor pathway inhibitor 2 |
chr8_+_22438009 | 3.53 |
ENST00000409417.1 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr16_-_65155833 | 3.50 |
ENST00000566827.1 ENST00000394156.3 ENST00000562998.1 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr1_-_57045228 | 3.48 |
ENST00000371250.3 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
chr7_-_107643674 | 3.44 |
ENST00000222399.6 |
LAMB1 |
laminin, beta 1 |
chr3_-_32022733 | 3.44 |
ENST00000438237.2 ENST00000396556.2 |
OSBPL10 |
oxysterol binding protein-like 10 |
chr8_+_22446763 | 3.44 |
ENST00000450780.2 ENST00000430850.2 ENST00000447849.1 |
AC037459.4 |
Uncharacterized protein |
chr5_+_102201509 | 3.43 |
ENST00000348126.2 ENST00000379787.4 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr12_-_15942503 | 3.40 |
ENST00000281172.5 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr15_+_74218787 | 3.37 |
ENST00000261921.7 |
LOXL1 |
lysyl oxidase-like 1 |
chr1_+_114522049 | 3.37 |
ENST00000369551.1 ENST00000320334.4 |
OLFML3 |
olfactomedin-like 3 |
chr3_-_185542761 | 3.35 |
ENST00000457616.2 ENST00000346192.3 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_123411191 | 3.30 |
ENST00000354792.5 ENST00000508240.1 |
MYLK |
myosin light chain kinase |
chr9_+_124030338 | 3.23 |
ENST00000449773.1 ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN |
gelsolin |
chr11_-_35547151 | 3.20 |
ENST00000378878.3 ENST00000529303.1 ENST00000278360.3 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
chr21_-_28338732 | 3.18 |
ENST00000284987.5 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr10_-_126849068 | 3.17 |
ENST00000494626.2 ENST00000337195.5 |
CTBP2 |
C-terminal binding protein 2 |
chrX_+_73641286 | 3.16 |
ENST00000587091.1 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr16_+_31483374 | 3.13 |
ENST00000394863.3 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
chr21_-_28217721 | 3.13 |
ENST00000284984.3 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr1_-_225840747 | 3.07 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr8_-_23261589 | 3.07 |
ENST00000524168.1 ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2 |
lysyl oxidase-like 2 |
chr11_-_111781610 | 3.06 |
ENST00000525823.1 |
CRYAB |
crystallin, alpha B |
chr11_-_2160180 | 3.03 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr11_-_2158507 | 3.00 |
ENST00000381392.1 ENST00000381395.1 ENST00000418738.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr6_+_151561085 | 3.00 |
ENST00000402676.2 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr6_+_86159765 | 2.95 |
ENST00000369646.3 ENST00000257770.3 |
NT5E |
5'-nucleotidase, ecto (CD73) |
chr8_+_30241934 | 2.95 |
ENST00000538486.1 |
RBPMS |
RNA binding protein with multiple splicing |
chr1_-_95392635 | 2.92 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr3_-_120170052 | 2.91 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr1_-_93426998 | 2.86 |
ENST00000370310.4 |
FAM69A |
family with sequence similarity 69, member A |
chr2_-_238323007 | 2.79 |
ENST00000295550.4 |
COL6A3 |
collagen, type VI, alpha 3 |
chr4_+_169753156 | 2.79 |
ENST00000393726.3 ENST00000507735.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr2_-_216300784 | 2.79 |
ENST00000421182.1 ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1 |
fibronectin 1 |
chr11_+_117070037 | 2.78 |
ENST00000392951.4 ENST00000525531.1 ENST00000278968.6 |
TAGLN |
transgelin |
chr3_-_185542817 | 2.78 |
ENST00000382199.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr7_+_100770328 | 2.77 |
ENST00000223095.4 ENST00000445463.2 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr16_+_56642041 | 2.77 |
ENST00000245185.5 |
MT2A |
metallothionein 2A |
chrX_+_102631844 | 2.76 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr6_+_86159821 | 2.73 |
ENST00000369651.3 |
NT5E |
5'-nucleotidase, ecto (CD73) |
chr2_-_224903995 | 2.73 |
ENST00000409304.1 ENST00000454956.1 ENST00000258405.4 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr15_+_63334831 | 2.72 |
ENST00000288398.6 ENST00000358278.3 ENST00000560445.1 ENST00000403994.3 ENST00000357980.4 ENST00000559556.1 ENST00000559397.1 ENST00000267996.7 ENST00000560970.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr17_+_1665253 | 2.69 |
ENST00000254722.4 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr7_+_79764104 | 2.69 |
ENST00000351004.3 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr2_-_238322770 | 2.67 |
ENST00000472056.1 |
COL6A3 |
collagen, type VI, alpha 3 |
chr4_+_47487285 | 2.66 |
ENST00000273859.3 ENST00000504445.1 |
ATP10D |
ATPase, class V, type 10D |
chr12_+_66217911 | 2.65 |
ENST00000403681.2 |
HMGA2 |
high mobility group AT-hook 2 |
chr9_-_21974820 | 2.63 |
ENST00000579122.1 ENST00000498124.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr19_-_50143452 | 2.62 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chr13_+_110959598 | 2.59 |
ENST00000360467.5 |
COL4A2 |
collagen, type IV, alpha 2 |
chr3_+_157154578 | 2.59 |
ENST00000295927.3 |
PTX3 |
pentraxin 3, long |
chr15_+_63335899 | 2.59 |
ENST00000561266.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr1_-_95007193 | 2.58 |
ENST00000370207.4 ENST00000334047.7 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
chr2_-_175870085 | 2.56 |
ENST00000409156.3 |
CHN1 |
chimerin 1 |
chr7_-_150038704 | 2.55 |
ENST00000466675.1 ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2 |
retinoic acid receptor responder (tazarotene induced) 2 |
chr16_+_31483451 | 2.55 |
ENST00000565360.1 ENST00000361773.3 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
chr3_-_49170522 | 2.55 |
ENST00000418109.1 |
LAMB2 |
laminin, beta 2 (laminin S) |
chr5_-_127873659 | 2.54 |
ENST00000262464.4 |
FBN2 |
fibrillin 2 |
chrX_+_100805496 | 2.53 |
ENST00000372829.3 |
ARMCX1 |
armadillo repeat containing, X-linked 1 |
chrX_+_102631248 | 2.53 |
ENST00000361298.4 ENST00000372645.3 ENST00000372635.1 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr5_+_92919043 | 2.51 |
ENST00000327111.3 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
chr3_-_149688655 | 2.51 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr1_-_153538011 | 2.50 |
ENST00000368707.4 |
S100A2 |
S100 calcium binding protein A2 |
chr8_+_30241995 | 2.50 |
ENST00000397323.4 ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS |
RNA binding protein with multiple splicing |
chr3_+_154797428 | 2.46 |
ENST00000460393.1 |
MME |
membrane metallo-endopeptidase |
chr12_-_15942309 | 2.45 |
ENST00000544064.1 ENST00000543523.1 ENST00000536793.1 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr14_-_53417732 | 2.44 |
ENST00000399304.3 ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2 |
fermitin family member 2 |
chr12_+_6309963 | 2.43 |
ENST00000382515.2 |
CD9 |
CD9 molecule |
chr5_+_148521046 | 2.43 |
ENST00000326685.7 ENST00000356541.3 ENST00000309868.7 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr1_+_64059332 | 2.43 |
ENST00000540265.1 |
PGM1 |
phosphoglucomutase 1 |
chr2_-_238322800 | 2.43 |
ENST00000392004.3 ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3 |
collagen, type VI, alpha 3 |
chr11_+_19799327 | 2.41 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr11_-_111781454 | 2.40 |
ENST00000533280.1 |
CRYAB |
crystallin, alpha B |
chr7_-_24797032 | 2.39 |
ENST00000409970.1 ENST00000409775.3 |
DFNA5 |
deafness, autosomal dominant 5 |
chr3_-_79068594 | 2.39 |
ENST00000436010.2 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr8_-_42065187 | 2.38 |
ENST00000270189.6 ENST00000352041.3 ENST00000220809.4 |
PLAT |
plasminogen activator, tissue |
chr1_-_153599732 | 2.37 |
ENST00000392623.1 |
S100A13 |
S100 calcium binding protein A13 |
chr18_+_7754957 | 2.35 |
ENST00000400053.4 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
chr7_+_32996997 | 2.33 |
ENST00000242209.4 ENST00000538336.1 ENST00000538443.1 |
FKBP9 |
FK506 binding protein 9, 63 kDa |
chr12_-_106641728 | 2.33 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr3_-_55521323 | 2.32 |
ENST00000264634.4 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
chr2_+_201450591 | 2.31 |
ENST00000374700.2 |
AOX1 |
aldehyde oxidase 1 |
chr11_-_111781554 | 2.30 |
ENST00000526167.1 ENST00000528961.1 |
CRYAB |
crystallin, alpha B |
chr3_-_49170405 | 2.28 |
ENST00000305544.4 ENST00000494831.1 |
LAMB2 |
laminin, beta 2 (laminin S) |
chr7_+_130126165 | 2.28 |
ENST00000427521.1 ENST00000416162.2 ENST00000378576.4 |
MEST |
mesoderm specific transcript |
chr9_-_21995300 | 2.27 |
ENST00000498628.2 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr19_-_19051927 | 2.26 |
ENST00000600077.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr16_+_56703737 | 2.24 |
ENST00000569155.1 |
MT1H |
metallothionein 1H |
chr7_-_151329416 | 2.24 |
ENST00000418337.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr19_-_58609570 | 2.24 |
ENST00000600845.1 ENST00000240727.6 ENST00000600897.1 ENST00000421612.2 ENST00000601063.1 ENST00000601144.1 |
ZSCAN18 |
zinc finger and SCAN domain containing 18 |
chr19_-_19051993 | 2.23 |
ENST00000594794.1 ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr9_+_124062071 | 2.22 |
ENST00000373818.4 |
GSN |
gelsolin |
chr1_-_153600656 | 2.22 |
ENST00000339556.4 ENST00000440685.2 |
S100A13 |
S100 calcium binding protein A13 |
chr2_-_169104651 | 2.22 |
ENST00000355999.4 |
STK39 |
serine threonine kinase 39 |
chr1_-_68698222 | 2.20 |
ENST00000370976.3 ENST00000354777.2 ENST00000262348.4 ENST00000540432.1 |
WLS |
wntless Wnt ligand secretion mediator |
chr2_+_235860616 | 2.18 |
ENST00000392011.2 |
SH3BP4 |
SH3-domain binding protein 4 |
chr1_-_153517473 | 2.18 |
ENST00000368715.1 |
S100A4 |
S100 calcium binding protein A4 |
chr5_-_39425222 | 2.18 |
ENST00000320816.6 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chr16_-_56701933 | 2.18 |
ENST00000568675.1 ENST00000569500.1 ENST00000444837.2 ENST00000379811.3 |
MT1G |
metallothionein 1G |
chr2_-_1748214 | 2.18 |
ENST00000433670.1 ENST00000425171.1 ENST00000252804.4 |
PXDN |
peroxidasin homolog (Drosophila) |
chr11_+_2923423 | 2.17 |
ENST00000312221.5 |
SLC22A18 |
solute carrier family 22, member 18 |
chr6_+_151561506 | 2.16 |
ENST00000253332.1 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr17_-_46115122 | 2.16 |
ENST00000006101.4 |
COPZ2 |
coatomer protein complex, subunit zeta 2 |
chr5_+_17217669 | 2.15 |
ENST00000322611.3 |
BASP1 |
brain abundant, membrane attached signal protein 1 |
chr19_+_48281928 | 2.15 |
ENST00000593892.1 |
SEPW1 |
selenoprotein W, 1 |
chr12_-_8803128 | 2.15 |
ENST00000543467.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr8_-_67525473 | 2.15 |
ENST00000522677.3 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
chr4_-_114900831 | 2.14 |
ENST00000315366.7 |
ARSJ |
arylsulfatase family, member J |
chr3_-_114866084 | 2.14 |
ENST00000357258.3 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr1_-_153508460 | 2.14 |
ENST00000462776.2 |
S100A6 |
S100 calcium binding protein A6 |
chr4_-_157892498 | 2.14 |
ENST00000502773.1 |
PDGFC |
platelet derived growth factor C |
chr7_-_107642348 | 2.14 |
ENST00000393561.1 |
LAMB1 |
laminin, beta 1 |
chr3_-_134093395 | 2.13 |
ENST00000249883.5 |
AMOTL2 |
angiomotin like 2 |
chr5_+_135394840 | 2.13 |
ENST00000503087.1 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr1_+_204797749 | 2.12 |
ENST00000367172.4 ENST00000367171.4 ENST00000367170.4 ENST00000338515.6 ENST00000339876.6 ENST00000338586.6 ENST00000539706.1 ENST00000360049.4 ENST00000367169.4 ENST00000446412.1 ENST00000403080.1 |
NFASC |
neurofascin |
chr1_-_153588334 | 2.11 |
ENST00000476873.1 |
S100A14 |
S100 calcium binding protein A14 |
chr1_+_17944806 | 2.11 |
ENST00000375408.3 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr9_-_74383799 | 2.11 |
ENST00000377044.4 |
TMEM2 |
transmembrane protein 2 |
chr4_-_102268628 | 2.10 |
ENST00000323055.6 ENST00000512215.1 ENST00000394854.3 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr19_+_41725088 | 2.10 |
ENST00000301178.4 |
AXL |
AXL receptor tyrosine kinase |
chr6_+_123110465 | 2.09 |
ENST00000539041.1 |
SMPDL3A |
sphingomyelin phosphodiesterase, acid-like 3A |
chr2_-_55277654 | 2.09 |
ENST00000337526.6 ENST00000317610.7 ENST00000357732.4 |
RTN4 |
reticulon 4 |
chr3_-_49395705 | 2.09 |
ENST00000419349.1 |
GPX1 |
glutathione peroxidase 1 |
chr20_+_53092123 | 2.08 |
ENST00000262593.5 |
DOK5 |
docking protein 5 |
chr3_-_98620500 | 2.07 |
ENST00000326840.6 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
chr16_+_56703703 | 2.07 |
ENST00000332374.4 |
MT1H |
metallothionein 1H |
chrX_-_101771645 | 2.07 |
ENST00000289373.4 |
TMSB15A |
thymosin beta 15a |
chr22_-_36236623 | 2.06 |
ENST00000405409.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr12_-_124457371 | 2.06 |
ENST00000238156.3 ENST00000545037.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr9_-_35685452 | 2.06 |
ENST00000607559.1 |
TPM2 |
tropomyosin 2 (beta) |
chr3_-_124606074 | 2.05 |
ENST00000296181.4 |
ITGB5 |
integrin, beta 5 |
chr5_+_135364584 | 2.05 |
ENST00000442011.2 ENST00000305126.8 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr3_-_149688502 | 2.05 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr17_+_1665345 | 2.05 |
ENST00000576406.1 ENST00000571149.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr5_+_52776449 | 2.03 |
ENST00000396947.3 |
FST |
follistatin |
chr2_+_120124497 | 2.02 |
ENST00000355857.3 ENST00000535617.1 ENST00000535757.1 ENST00000409094.1 ENST00000311521.4 |
DBI |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
chr12_+_110718921 | 2.02 |
ENST00000308664.6 |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
chr3_-_55523966 | 2.02 |
ENST00000474267.1 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
chr2_+_46926326 | 2.02 |
ENST00000394861.2 |
SOCS5 |
suppressor of cytokine signaling 5 |
chr20_+_19867150 | 2.02 |
ENST00000255006.6 |
RIN2 |
Ras and Rab interactor 2 |
chr7_+_94023873 | 2.01 |
ENST00000297268.6 |
COL1A2 |
collagen, type I, alpha 2 |
chr2_+_192141611 | 2.00 |
ENST00000392316.1 |
MYO1B |
myosin IB |
chr12_+_119616447 | 2.00 |
ENST00000281938.2 |
HSPB8 |
heat shock 22kDa protein 8 |
chr2_-_55277692 | 1.99 |
ENST00000394611.2 |
RTN4 |
reticulon 4 |
chr18_+_8717369 | 1.99 |
ENST00000359865.3 ENST00000400050.3 ENST00000306285.7 |
SOGA2 |
SOGA family member 2 |
chr3_-_127441406 | 1.99 |
ENST00000487473.1 ENST00000484451.1 |
MGLL |
monoglyceride lipase |
chr6_+_151662815 | 1.98 |
ENST00000359755.5 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr5_-_72744336 | 1.97 |
ENST00000499003.3 |
FOXD1 |
forkhead box D1 |
chr2_-_227664474 | 1.96 |
ENST00000305123.5 |
IRS1 |
insulin receptor substrate 1 |
chr8_+_70404996 | 1.96 |
ENST00000402687.4 ENST00000419716.3 |
SULF1 |
sulfatase 1 |
chr5_+_150400124 | 1.95 |
ENST00000388825.4 ENST00000521650.1 ENST00000517973.1 |
GPX3 |
glutathione peroxidase 3 (plasma) |
chr9_-_113800981 | 1.95 |
ENST00000538760.1 |
LPAR1 |
lysophosphatidic acid receptor 1 |
chr10_+_88728189 | 1.95 |
ENST00000416348.1 |
ADIRF |
adipogenesis regulatory factor |
chr16_-_28550348 | 1.94 |
ENST00000324873.6 |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
chrX_-_34675391 | 1.94 |
ENST00000275954.3 |
TMEM47 |
transmembrane protein 47 |
chr8_+_54793425 | 1.94 |
ENST00000522225.1 |
RGS20 |
regulator of G-protein signaling 20 |
chr8_-_42065075 | 1.93 |
ENST00000429089.2 ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT |
plasminogen activator, tissue |
chr12_+_6308881 | 1.93 |
ENST00000382518.1 ENST00000536586.1 |
CD9 |
CD9 molecule |
chr1_+_156052354 | 1.92 |
ENST00000368301.2 |
LMNA |
lamin A/C |
chr1_-_103574024 | 1.91 |
ENST00000512756.1 ENST00000370096.3 ENST00000358392.2 ENST00000353414.4 |
COL11A1 |
collagen, type XI, alpha 1 |
chr12_-_47473425 | 1.90 |
ENST00000550413.1 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr11_+_19798964 | 1.90 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.8 | 7.0 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
1.7 | 1.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.7 | 6.8 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.6 | 11.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.2 | 3.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.2 | 18.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.1 | 5.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 17.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.0 | 7.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.0 | 11.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 3.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.0 | 5.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 5.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
1.0 | 5.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.0 | 10.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 4.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.9 | 6.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.8 | 5.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.8 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 2.4 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.8 | 4.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.8 | 3.2 | GO:0017022 | myosin binding(GO:0017022) |
0.8 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 3.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.8 | 2.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.7 | 2.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 2.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.7 | 12.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 21.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 2.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.7 | 2.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.7 | 2.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 2.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 2.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 1.9 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.6 | 5.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 43.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.6 | 5.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.6 | 2.4 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.6 | 9.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.6 | 3.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 1.7 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.5 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 2.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
0.5 | 1.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 3.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 1.6 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.5 | 3.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 5.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 2.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.5 | 11.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 0.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.5 | 1.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 3.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 5.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.5 | 1.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 4.4 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 1.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 2.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.5 | 4.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 2.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 2.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 40.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 1.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.5 | 6.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.5 | 4.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 5.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 9.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 5.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 2.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 6.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.4 | 6.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 5.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 2.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.4 | 7.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 1.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.4 | 3.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 39.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 4.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.4 | 3.0 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 3.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 1.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.4 | 3.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 2.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.4 | 1.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 6.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.4 | 1.4 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.4 | 1.8 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.4 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 1.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 10.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 6.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.3 | 1.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.3 | 2.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 1.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 2.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 33.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.3 | 1.0 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.3 | 13.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 3.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 2.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 3.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.0 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 3.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.6 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.3 | 1.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 2.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.8 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.3 | 8.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 2.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 4.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.3 | 0.9 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.3 | 2.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 2.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 4.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 4.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 2.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 2.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.3 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 3.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 2.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.8 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.3 | 4.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 7.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 3.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 2.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 0.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 2.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 6.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 3.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 0.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.4 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 1.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 2.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 5.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 0.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 5.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.2 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.0 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 3.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 3.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 2.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.8 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 1.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 2.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.8 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 2.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.2 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.4 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 1.0 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 2.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.7 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 6.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 5.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.2 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.5 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 2.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 3.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 4.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 1.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 1.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 3.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 16.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 2.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 2.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 2.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.6 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.1 | 2.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 1.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 3.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.4 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.1 | 1.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 4.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 13.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 2.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 19.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 2.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 3.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 3.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.5 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.1 | 0.3 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 3.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 2.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 2.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 2.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 5.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 7.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 33.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 23.0 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 1.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 2.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 1.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 7.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 9.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.0 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 5.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.0 | 0.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.0 | GO:0048406 | nerve growth factor receptor activity(GO:0010465) nerve growth factor binding(GO:0048406) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 20.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 61.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.7 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 14.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 3.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 21.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 19.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 21.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 8.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 5.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 7.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 20.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 10.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 53.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 8.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 70.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 2.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 13.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 6.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 20.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 7.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 13.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 8.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 11.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 6.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 7.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 3.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 13.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 5.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 6.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 17.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 3.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 5.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 5.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 4.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 6.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.7 | 5.1 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.6 | 4.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 24.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.3 | 14.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.2 | 16.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.2 | 21.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.1 | 3.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.0 | 1.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.0 | 6.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.9 | 12.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.9 | 7.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.9 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 3.4 | GO:0031673 | H zone(GO:0031673) |
0.8 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.8 | 7.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 1.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.8 | 6.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 3.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.8 | 5.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.8 | 7.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 3.1 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.8 | 5.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 2.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 11.5 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 6.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 2.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 2.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 9.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 4.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 6.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 7.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.7 | 7.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 0.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 10.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.6 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 6.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 3.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.6 | 57.3 | GO:0005604 | basement membrane(GO:0005604) |
0.6 | 2.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.6 | 12.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 4.9 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 11.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 3.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 1.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 8.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 3.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 7.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 2.0 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 1.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.4 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 3.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 10.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 7.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 1.5 | GO:0032449 | CBM complex(GO:0032449) |
0.4 | 1.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 2.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 3.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 4.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.3 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 4.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 2.6 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 2.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 2.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 14.4 | GO:0043034 | costamere(GO:0043034) |
0.3 | 8.1 | GO:0031430 | M band(GO:0031430) |
0.3 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 1.5 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 3.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 2.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.3 | 2.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 2.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 8.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 26.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 4.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 2.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 3.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 63.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 0.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 6.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 8.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 18.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 7.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 4.0 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.6 | GO:0033643 | host cell part(GO:0033643) |
0.2 | 1.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 39.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.8 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 1.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 1.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 0.9 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 2.5 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 2.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 1.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.9 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 3.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 6.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 7.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 3.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 7.7 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 74.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 2.5 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.2 | 4.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.7 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.1 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 7.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 3.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 3.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.9 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 7.8 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 5.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.5 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 6.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 3.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 5.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 4.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 4.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 2.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 2.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 2.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 4.8 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.6 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 3.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 9.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 5.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.2 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 0.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 1.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 6.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 10.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 1.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 2.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 2.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 7.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 3.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.8 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 18.3 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.6 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.0 | GO:0043196 | varicosity(GO:0043196) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 23.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 27.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.7 | 42.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 6.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 5.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 33.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 16.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 9.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 21.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 14.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 8.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 9.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 7.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 9.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 4.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 6.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 6.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 8.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 6.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 5.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 5.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 6.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 35.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 7.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 5.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 3.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 3.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 5.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 4.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 8.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 5.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 4.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 7.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 3.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 4.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 2.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 3.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 13.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 3.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 15.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 10.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 3.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 3.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 6.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 3.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 7.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 5.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 3.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.2 | 6.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.0 | 10.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.8 | 5.3 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.8 | 7.0 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
1.7 | 5.1 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
1.7 | 8.5 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
1.6 | 6.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
1.5 | 4.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.4 | 5.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
1.4 | 12.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.3 | 14.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
1.3 | 1.3 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.3 | 6.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.3 | 5.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 3.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
1.3 | 5.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.3 | 5.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.2 | 21.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.2 | 3.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.2 | 7.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
1.2 | 4.7 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
1.2 | 3.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.2 | 3.5 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
1.1 | 3.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.1 | 11.1 | GO:0070141 | response to UV-A(GO:0070141) |
1.1 | 4.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.1 | 4.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.1 | 3.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
1.0 | 6.2 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.0 | 3.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
1.0 | 5.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.0 | 2.9 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
1.0 | 5.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.0 | 7.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.0 | 6.7 | GO:0008218 | bioluminescence(GO:0008218) |
1.0 | 10.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 2.8 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.9 | 8.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 2.8 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.9 | 9.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 5.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.9 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 2.7 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.9 | 3.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.9 | 4.4 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.9 | 1.8 | GO:0033292 | T-tubule organization(GO:0033292) |
0.9 | 7.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 7.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.9 | 6.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.9 | 2.6 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 3.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.8 | 5.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.8 | 4.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.8 | 4.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.8 | 5.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.8 | 3.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.8 | 0.8 | GO:0008306 | associative learning(GO:0008306) |
0.8 | 9.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.8 | 2.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.8 | 7.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 5.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.8 | 2.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.8 | 3.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.8 | 6.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.8 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 2.3 | GO:2000282 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.8 | 3.0 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.8 | 2.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.8 | 1.5 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.7 | 4.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 4.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 3.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.7 | 2.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 2.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 3.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 8.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 1.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.7 | 2.1 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.7 | 3.6 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.7 | 0.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 7.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.7 | 2.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.7 | 3.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.7 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 2.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.7 | 2.7 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.7 | 9.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.7 | 2.0 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 1.9 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 3.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 4.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.6 | 6.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.6 | 1.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.6 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 1.2 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.6 | 4.9 | GO:0046618 | drug export(GO:0046618) |
0.6 | 1.2 | GO:0001300 | chronological cell aging(GO:0001300) |
0.6 | 2.4 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
0.6 | 1.2 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.6 | 3.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 2.3 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 1.7 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 3.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 4.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 1.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 7.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 0.6 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.6 | 1.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.5 | 4.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.5 | 1.1 | GO:2000591 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 14.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 1.6 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 2.6 | GO:0030047 | actin modification(GO:0030047) |
0.5 | 3.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.5 | 3.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 15.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 5.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 11.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 6.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 3.6 | GO:0035878 | nail development(GO:0035878) |
0.5 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 1.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 0.5 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.5 | 3.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 1.5 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 1.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.5 | 2.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 0.5 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.5 | 2.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.5 | 0.5 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.5 | 2.5 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.5 | 6.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 0.5 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.5 | 3.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 3.9 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.5 | 1.5 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 1.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 3.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 1.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.5 | 2.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.5 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 0.5 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.5 | 1.0 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.5 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 1.0 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.5 | 2.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 2.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.5 | 1.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.5 | 7.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 3.3 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.5 | 1.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 5.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.5 | 1.4 | GO:0071529 | cementum mineralization(GO:0071529) |
0.5 | 6.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 3.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.5 | 3.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.5 | 0.9 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
0.4 | 0.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 1.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.4 | 4.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.4 | 0.4 | GO:1903825 | organic acid transmembrane transport(GO:1903825) |
0.4 | 1.3 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.3 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.3 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.4 | 0.9 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.4 | 3.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 0.4 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 0.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.4 | 4.8 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 3.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.4 | 3.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.4 | 1.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.4 | 1.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.4 | 0.9 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.4 | 1.7 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.4 | 1.7 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.4 | 11.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 1.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.4 | 2.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 3.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.4 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 2.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 2.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.4 | 1.2 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.4 | 0.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 2.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 3.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 2.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 0.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.4 | 1.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.4 | 1.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.4 | 1.6 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
0.4 | 2.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 1.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.4 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
0.4 | 1.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 1.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.4 | 3.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.4 | 4.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 1.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.4 | 6.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 1.1 | GO:1905066 | blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) canonical Wnt signaling pathway involved in heart development(GO:0061316) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) blood vessel endothelial cell fate specification(GO:0097101) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.4 | 1.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.4 | 0.4 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.4 | 1.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 3.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.4 | 6.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 0.7 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.4 | 1.5 | GO:0042335 | cuticle development(GO:0042335) |
0.4 | 1.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.4 | 5.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.8 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.4 | 0.4 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.4 | 1.5 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.4 | 21.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 0.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.4 | 1.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.4 | 1.8 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.4 | 2.2 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.4 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 2.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 2.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.3 | 1.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 3.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.3 | 2.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 1.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.0 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.3 | 0.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.3 | 1.7 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.0 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.3 | 0.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 1.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 2.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.3 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 11.5 | GO:0097435 | fibril organization(GO:0097435) |
0.3 | 1.0 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.3 | 0.3 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.3 | 0.9 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.3 | 0.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 0.6 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.3 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.3 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.3 | 0.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 2.5 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 0.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 0.9 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 1.2 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.3 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 0.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 0.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.3 | 0.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.9 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 0.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 0.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.3 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.9 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 8.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 3.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 5.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.3 | 3.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.3 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.3 | 1.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.3 | 2.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.3 | 0.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 1.7 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 0.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.3 | 0.9 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.3 | 1.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.9 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.3 | 0.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.3 | 4.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 2.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 3.9 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.3 | 0.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.3 | 0.5 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.3 | 1.6 | GO:0060281 | regulation of oocyte development(GO:0060281) regulation of oocyte maturation(GO:1900193) |
0.3 | 6.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 6.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 3.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 0.5 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.3 | 4.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 0.8 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.3 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 1.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.3 | 0.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 0.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.3 | 0.8 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.3 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
0.3 | 0.8 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.3 | 2.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 3.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 2.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 2.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 3.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 1.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 | 0.5 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 1.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 2.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 4.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.5 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 0.5 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.2 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.2 | 1.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 2.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.2 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.5 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 2.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.5 | GO:0035136 | embryonic forelimb morphogenesis(GO:0035115) forelimb morphogenesis(GO:0035136) |
0.2 | 0.5 | GO:1900390 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.2 | 0.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 5.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 3.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.9 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 1.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 1.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.7 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.2 | 1.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.2 | 0.4 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.2 | 1.8 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.2 | 4.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 4.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 0.7 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.2 | 0.2 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.2 | 0.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 2.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.9 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 1.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.7 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.2 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 1.9 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.2 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 4.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.9 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.2 | 0.6 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.2 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 4.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.0 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 | 0.6 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.2 | 1.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 0.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 9.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.4 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.4 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.2 | 0.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
0.2 | 5.1 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 1.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 1.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 0.6 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
0.2 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 2.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.2 | 0.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 1.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.4 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
0.2 | 1.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.8 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 1.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.2 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.2 | 0.4 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 1.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.4 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.2 | 1.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 1.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.7 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.4 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.2 | 0.6 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 3.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 3.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.2 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 2.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.5 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.2 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.9 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 0.3 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 11.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.2 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.2 | 2.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.5 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 2.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.2 | 0.7 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.2 | 11.4 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.2 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
0.2 | 0.7 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.2 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 2.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 3.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.7 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.8 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 | 1.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.5 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.2 | 0.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.8 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.2 | 0.5 | GO:1903008 | organelle disassembly(GO:1903008) |
0.2 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 0.6 | GO:0035900 | response to isolation stress(GO:0035900) |
0.2 | 0.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.3 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.2 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 3.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 0.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
0.2 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 2.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.4 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 1.5 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 4.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 0.1 | GO:0071726 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.1 | 0.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 2.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 0.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.1 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.3 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 1.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 2.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 1.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 1.6 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 1.8 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.4 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.4 | GO:1904617 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.5 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 0.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.1 | 0.1 | GO:0042363 | fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 1.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.8 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.7 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.7 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.7 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.5 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.1 | 0.3 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.1 | 2.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 1.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.1 | 1.0 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.6 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.5 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.1 | 1.0 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 2.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.5 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 2.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.6 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.2 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 1.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 2.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 1.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 3.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.4 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.1 | 2.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.9 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.1 | 0.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.1 | 0.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 2.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 3.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.3 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.1 | 2.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 2.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.1 | 3.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.1 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.1 | GO:0051342 | sensory perception of umami taste(GO:0050917) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.3 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 3.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.2 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.1 | 0.8 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.5 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.1 | 1.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.1 | 0.3 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.6 | GO:0010756 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.4 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.2 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.1 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.3 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.5 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 1.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 2.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
0.1 | 1.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 2.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.8 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 1.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 3.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.3 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.5 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 4.9 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 4.6 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.4 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.7 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 3.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 | 0.8 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.8 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 4.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 1.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.1 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 1.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 2.7 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.3 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 0.8 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 1.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.6 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.2 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.4 | GO:0042426 | choline catabolic process(GO:0042426) |
0.1 | 0.1 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.1 | 0.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.2 | GO:0055062 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0042320 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) negative regulation of urine volume(GO:0035811) regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.1 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:1990774 | tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.1 | 0.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 1.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.4 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) ketone body metabolic process(GO:1902224) |
0.1 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.9 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.3 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 2.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.1 | 1.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.2 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 1.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 3.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 2.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 1.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 3.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.5 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.1 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.1 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.1 | 0.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 2.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.1 | 0.1 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 0.2 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 1.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 1.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.3 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.0 | 0.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.0 | GO:0043578 | nuclear matrix organization(GO:0043578) |
0.0 | 2.1 | GO:0048675 | axon extension(GO:0048675) |
0.0 | 0.1 | GO:0098598 | learned vocalization behavior or vocal learning(GO:0098598) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0016128 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.0 | 0.0 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.0 | 1.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 1.4 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 1.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.0 | 0.1 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.1 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 1.2 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 1.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0042436 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 5.6 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.0 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 0.0 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.0 | 0.0 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.0 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.0 | 0.5 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0034103 | regulation of tissue remodeling(GO:0034103) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
0.0 | 0.0 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.3 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 2.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) DNA dephosphorylation(GO:0098502) |
0.0 | 0.1 | GO:1900272 | microglial cell activation involved in immune response(GO:0002282) negative regulation of long-term synaptic potentiation(GO:1900272) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 1.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 3.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.0 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.4 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.0 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.9 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.2 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:1901342 | regulation of vasculature development(GO:1901342) |
0.0 | 0.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.2 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.7 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 0.0 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.0 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0097352 | autophagosome maturation(GO:0097352) |